Naldemedine (Symproic)

naldemedine · Shionogi & Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Naldemedine (Symproic), covering 2025-07-02 to 2025-07-02. Get the full timeline:

Most recent: Clinical Trial Update: Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study [Phase 4]

See pricing